Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04168671
Other study ID # HUS/886/2018
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date December 31, 2021

Study information

Verified date July 2022
Source Helsinki University Central Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose is to assess visualize the level of laryngeal obstruction and vocal cord dysfunction and to obtain more information on causes for dyspnea in asthma and severe asthma and to assess safety of CLE in patients with asthma and with severe asthma. Patients are examined if symptomatic during exercise.


Description:

- Questionnaires to assess breathlessness before the test. - CLE on ergometer bicycle using any laryngoscopy setup - Ergometry with spirometry tests with ECG, oxygen saturation, blood pressure, inspiratory and expiratory flow volume curves, bronchodilator after the exercise test - Work load of 40W with 3 minutes intervals and increase by 40W in women. In men, work load of 50W with 3 minutes intervals and increase by 50W starting from 50W. In elderly and more severely disease work load of 30W with 3 minutes intervals and increase by 30W. - Recording of dyspnoea, leg fatigue and chest discomfort - Assessment of asthma by asthma control test, spirometry, exhaled NO measurements. - Severe asthma group: physician-diagnosed asthma, moderate-high dose inhaled glucorticoid steroids and a second controller drug, exacerbations and per oral glucocorticoid steroid courses at least 2 in the past 12 months and/or 50% of the past 12 months on per oral glucocorticoidsteroids


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - physician diagnosed asthma - symptomatic during exercise Exclusion Criteria: - FEV1 <60% - respiratory infection in the last 14 days - asthma excacerbation in the last 14 days - unstable cardiovascular disease - bleeding disorder - anticoagulant treatment (other than ASA)

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Continuous laryngoscopy during exercise test
Continuous laryngoscopy during exercise test

Locations

Country Name City State
Finland Helsinki University Central Hospital Helsinki

Sponsors (1)

Lead Sponsor Collaborator
Helsinki University Central Hospital

Country where clinical trial is conducted

Finland, 

References & Publications (2)

Bardin PG, Low K, Ruane L, Lau KK. Controversies and conundrums in vocal cord dysfunction. Lancet Respir Med. 2017 Jul;5(7):546-548. doi: 10.1016/S2213-2600(17)30221-7. — View Citation

Lawlor C, Smithers CJ, Hamilton T, Baird C, Rahbar R, Choi S, Jennings R. Innovative management of severe tracheobronchomalacia using anterior and posterior tracheobronchopexy. Laryngoscope. 2020 Feb;130(2):E65-E74. doi: 10.1002/lary.27938. Epub 2019 Mar 25. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Laryngeal obstruction Semi-quantitative visual estimation of laryngeal obstruction in test From immediately before (-5 minutes) before the exercise test, during the test up to 30 minutes
Secondary Safety of CLE in asthma (Incidence of test-emergent adverse events) Incidence of test-emergent adverse events: nasal bleeding or pain, panic attack, bronchial obstruction. From immediately before (-10 minutes) before the exercise test, during the test up to 30 minutes
Secondary Exercise capacity in CLE in asthma Maximal work load in exercise test measured by W max 4 min From 0 minutes before the exercise test and during the test up to 30 minutes
Secondary Dyspnea in CLE in asthma Assessment of patient reported dyspnea in maximal exercise measured by scale from 0 to 10 (Borg's scale) (0 no symptoms - 10 maximal dyspnea) From 0 minutes before the exercise test and during the test up to 30 minutes
Secondary Exercise induced lung function changes Change from baseline FEV1 after the test Immediately before test (0 minutes), and 10 minutes and 20 minutes after the test
See also
  Status Clinical Trial Phase
Completed NCT05746780 - Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
Active, not recruiting NCT03529422 - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Phase 2
Completed NCT02126969 - A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN Phase 2
Completed NCT01263873 - Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube N/A
Completed NCT03162731 - Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer Early Phase 1
Enrolling by invitation NCT03269396 - Laryngeal Allograft Transplantation N/A
Completed NCT01649973 - Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy N/A
Completed NCT01321892 - Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium N/A
Recruiting NCT05636410 - Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period
Recruiting NCT05565430 - Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.
Completed NCT03109873 - Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer Early Phase 1
Active, not recruiting NCT03737968 - Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. Phase 2
Recruiting NCT03109171 - Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea N/A
Completed NCT02761239 - Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve N/A
Recruiting NCT05145556 - Teach Intubation by Novices in Anaesthesiology N/A
Completed NCT03030781 - Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging. N/A
Completed NCT03238365 - Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck Early Phase 1
Withdrawn NCT02065128 - The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome N/A
Active, not recruiting NCT03854032 - Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Phase 2
Active, not recruiting NCT03076281 - Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery Phase 2